Rowland Charles A Jr

CIK 000138329210 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001383292

Recent Transactions

50 trades

Disposition to Issuer
Generation Bio Co.$GBIO
Stock Option (right to buy)
2026-02-09−6,000→ 0 total
Disposition to Issuer
Generation Bio Co.$GBIO
Stock Option (right to buy)
2026-02-09−3,000→ 0 total
Disposition to Issuer
Generation Bio Co.$GBIO
Stock Option (right to buy)
2026-02-09−1,500→ 0 total
Disposition to Issuer
Generation Bio Co.$GBIO
Stock Option (right to buy)
2026-02-09−4,246→ 0 total
Disposition to Issuer
Generation Bio Co.$GBIO
Stock Option (right to buy)
2026-02-09−5,200→ 0 total
Disposition to Issuer
Generation Bio Co.$GBIO
Stock Option (right to buy)
2026-02-09−1,920→ 0 total
Disposition from Tender
Generation Bio Co.$GBIO
Common Stock
2026-02-09−53,475→ 0 total
Disposition to Issuer
Generation Bio Co.$GBIO
Stock Option (right to buy)
2026-02-09−2,500→ 0 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2026-01-02+20,400→ 20,400 total
Award
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2026-01-02+3,150→ 33,150 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2025-10-27−22,000→ 0 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2025-10-27−16,000→ 0 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2025-10-27$35.57/sh−60,000→ 30,000 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2025-10-27−22,000→ 0 total
Award
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2025-10-27$4.88/sh+22,000→ 90,000 total
Award
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2025-10-27$4.48/sh+16,000→ 46,000 total
Award
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2025-10-27$5.80/sh+22,000→ 68,000 total
Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2025-06-04+30,000→ 30,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2025-01-02+18,800→ 18,800 total
Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2024-06-06+60,000→ 60,000 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2024-01-24−46,000→ 0 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2024-01-24−105,000→ 0 total
Disposition to Issuer
Orchard Therapeutics plc
Ordinary Shares
2024-01-24−12,294→ 0 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2024-01-02+32,000→ 32,000 total
Purchase
Generation Bio Co.$GBIO
Common Stock
2023-12-04$1.50/sh+150,000→ 534,757 total
Purchase
Generation Bio Co.$GBIO
Common Stock
2023-12-01$1.31/sh+192,960→ 384,757 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2023-06-14+105,000→ 105,000 total
Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2023-06-08+25,000→ 25,000 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2023-05-16−40,000→ 0 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2023-05-16$25.00/sh−40,000→ 30,000 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2023-05-16$1.08/sh+40,000→ 70,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2023-01-03+22,000→ 22,000 total
Purchase
Generation Bio Co.$GBIO
Common Stock
2022-09-19$5.26/sh+15,750→ 191,797 total
Purchase
Generation Bio Co.$GBIO
Common Stock
2022-09-16$5.48/sh+33,481→ 176,047 total
Purchase
Generation Bio Co.$GBIO
Common Stock
2022-09-15$5.41/sh+17,147→ 142,566 total
Purchase
Generation Bio Co.$GBIO
Common Stock
2022-09-14$5.29/sh+5,600→ 125,419 total
Purchase
Generation Bio Co.$GBIO
Common Stock
2022-09-13$5.20/sh+18,784→ 119,819 total
Sale
Nabriva Therapeutics plc
Ordinary Shares
2022-08-01$0.17/sh−8,496→ 15,277 total
Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2022-06-09+19,200→ 19,200 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-06-07+46,000→ 46,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2022-01-03+22,000→ 22,000 total
Sale
Nabriva Therapeutics plc
Ordinary Shares
2021-08-02$1.20/sh−777→ 23,773 total
Award
Nabriva Therapeutics plc
Ordinary Shares
2021-07-28+17,500→ 24,550 total
Award
Nabriva Therapeutics plc
Share Options
2021-07-28+35,000→ 35,000 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2021-06-16+40,000→ 40,000 total
Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2021-06-09+15,000→ 15,000 total
Award
Blueprint Medicines Corp
Common Stock
2021-06-02+2,250→ 5,812 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2021-06-02+4,500→ 4,500 total
Purchase
Generation Bio Co.$GBIO
Common Stock
2021-01-11$24.50/sh+20,408→ 101,035 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2021-01-04+22,000→ 22,000 total

Companies

Recent Filings

Address

C/O GENERATION BIO CO. 301 BINNEY ST, SUITE 401

CAMBRIDGE, MA, 02142

View on SEC.gov